Ads
related to: t-cell therapy- See ALL Treatment Option
Watch A Treatment Overview Video
& Review Clinical Study Results
- Safety & Side Effect Info
View Adult Safety Info And Examine
Possible Adverse Reactions
- HCP Dosing Information
Learn about dosing information
For a Treatment option in ALL
- MRD B-Cell ALL Treatment
Learn More About An FDA-Approved
MRD B-Cell ALL Treatment Option
- Find MRD Testing For ALL
Explore The HCP Support Center And
Connect With Access Specialists
- Availdable HCP Resources
Download Helpful Resources
To Help Prepare Your Patients
- See ALL Treatment Option
Search results
Cullinan rebrands, halts lymphoma trial to reflect autoimmune refocus
FierceBiotech· 3 hours agoCullinan Therapeutics, as the biotech will now be known, is switching the focus of its CD19xCD3 T-...
Protein That Controls CAR T-Cell Longevity Identified
Technology Networks· 6 days agoCAR T cell therapy has revolutionized the way certain types of cancer are treated, and the longer...
Genentech axes Adaptimmune cell therapy deal as it presses ahead with staff cuts
FierceBiotech· 4 days agoIn the same week that Genentech confirmed it's cutting 3% of its staff, the Roche subsidiary has...
Adaptimmune (ADAP) Down on End of Collaboration With Roche
Zacks via Yahoo Finance· 23 hours agoThe regulatory body has set a target action date of Aug 4, 2024. Per the company, afami-cel would be...
ASTCT Supports the FDA's Approval of Earlier Use of CAR T-Cell Therapy for Multiple Myeloma
The Joplin Globe· 6 days agoThe Food and Drug Administration approves CAR T-Cell therapy Abecma as a second-line treatment and the CAR T-
New insights could unlock immunotherapy for rare, deadly eye cancer
Medical Xpress· 8 hours agoIn a paper published in Nature Communications, the Pitt researchers also explain how they developed...
T-cell therapy developer, Cbio A/S Unveils 2023 Annual Report Amid Clinical Trial Preparations,...
Morningstar· 4 days agoSØBORG, Denmark, April 12, 2024 (GLOBE NEWSWIRE) -- Cbio A/S – Pioneering Next-Gen T-Cell Therapies for Solid Tumors, Unveils 2023 Financial Results and ...
IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024
Morningstar· 7 days agoIN8bio, Inc. (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced new preclinical ...
...between Adaptimmune and Genentech to Research, Develop, and Commercialize Cancer-targeted...
Investing.com· 4 days agoPhiladelphia, Pennsylvania and Oxford, United Kindgom--(Newsfile Corp. - April 12, 2024) -...
Nanovials method for immune cell screening uncovers receptors that target prostate cancer
Phys.org· 21 hours agoThe research is published in the journal Proceedings of the National Academy of Sciences. The...
Ads
related to: t-cell therapy
